Transactions

FG Financial Group, Inc.

FG Financial Group, Inc.

$2.6 M
Follow-On Offering

Sole Book-Runner

Context Therapeutics Inc.

Context Therapeutics Inc.

$28.8 M
Initial Public Offering

Sole Book-Runner

Harbor Custom Development, Inc

Harbor Custom Development, Inc

$36 M
8% Series A Cumulative Convertible Preferred Stock

Sole Book-Runner

EzFill Holdings, Inc.

EzFill Holdings, Inc.

$28.8 M
IPO

Sole Book-Runner

Virpax Pharmaceuticals, Inc.

Virpax Pharmaceuticals, Inc.

$40 M
Follow-On Offering

Sole Book-Runner

authID.ai

authID.ai

$11.5 M
Follow-On Offering

Sole Book-Runner

ProPhase Labs, Inc.

ProPhase Labs, Inc.

$14.6 M
Acquisition of Nebula Genomics

Advisor

PetVivo Holdings, Inc.

PetVivo Holdings, Inc.

$11.3 M
Follow-On Offering

Sole Book-Runner

BioVie Inc.

BioVie Inc.

$20 M
Follow-On Offering

Sole Book-Runner

Draganfly Inc.

Draganfly Inc.

$20 M
Follow-On Offering

Sole Book-Runner

Opportunity Financial, LLC and FG New America Acquisition Corp.

Opportunity Financial, LLC and FG New America Acquisition Corp.

$800 M
Business Combination

Capital Markets Advisor

Twin Vee PowerCats Co.

Twin Vee PowerCats Co.

$18 M
IPO

Sole Book-Runner